Andreis Paola G, Malendowicz Ludwik K, Trejter Marcin, Neri Giuliano, Spinazzi Raffaella, Rossi Gian Paolo, Nussdorfer Gastone G
Department of Human Anatomy and Physiology, Section of Anatomy, School of Medicine, University of Padua, Via Gabelli 65, I-35121 Padua, Italy.
FEBS Lett. 2003 Feb 11;536(1-3):173-9. doi: 10.1016/s0014-5793(03)00051-6.
Ghrelin is an endogenous ligand of the growth hormone secretagogue receptor (GHS-R), which has been originally isolated from rat stomach. Evidence has been previously provided that adrenal gland possesses abundant ghrelin-displaceable GHS-Rs, but nothing is known about the possible role of ghrelin in the regulation of adrenocortical function. Reverse transcription-polymerase chain reaction demonstrated the expression of ghrelin and GHS-R in the rat adrenal cortex, and high adrenal concentrations of immunoreactive ghrelin were detected by radioimmune assay (RIA). Autoradiography localized abundant [(125)I]ghrelin binding sites in the adrenal zona glomerulosa (ZG) and outer zona fasciculata (ZF). Ghrelin (from 10(-10) to 10(-8) M) did not affect either basal steroid hormone (pregnenolone, progesterone, 11-deoxycorticosterone, corticosterone, 18-hydroxycorticosterone and aldosterone) secretion from dispersed ZG and zona fasciculata/reticularis (ZF/R) cells (as evaluated by quantitative high pressure liquid chromatography), or basal and agonist-stimulated aldosterone and corticosterone production from cultured ZG and ZF/R cells, respectively (as measured by RIA). Ghrelin (10(-8) and 10(-6) M) raised basal, but not agonist-stimulated, proliferation rate of cultured ZG cells (percent of cells able to incorporate 5-bromo-2'-deoxyuridine), without affecting apoptotic deletion rate (percent of cells able to incorporate biotinylated nucleosides into apoptotic DNA fragments). The tyrosine kinase (TK) inhibitor tyrphostin-23 and the p42/p44 mitogen-activated protein kinase (MAPK) inhibitor PD-98059 abolished the proliferogenic effect of 10(-8) M ghrelin, while the protein kinase A and C inhibitors H-89 and calphostin-C were ineffective. Ghrelin (10(-8) M) stimulated TK and MAPK activity of dispersed ZG cells, and the effect was abolished by preincubation with tyrphostin-23 and PD-98059, respectively. Tyrphostin-23 annulled ghrelin-induced activation of MAPK activity. Taken together, the present findings indicate that (i) ghrelin and GHS-R are both expressed in the rat adrenal cortex, ghrelin binding sites being very abundant in the ZG; (ii) ghrelin does not affect the secretory activity of rat adrenocortical cells, but significantly enhances the proliferation rate of cultured ZG cells, without affecting apoptotic deletion rate; and (iii) the ZG proliferogenic action of ghrelin involves the TK-dependent activation of the p42/p44 MAPK cascade.
胃饥饿素是生长激素促分泌素受体(GHS-R)的内源性配体,最初是从大鼠胃中分离出来的。先前已有证据表明肾上腺拥有丰富的可被胃饥饿素置换的GHS-R,但关于胃饥饿素在调节肾上腺皮质功能中可能发挥的作用却一无所知。逆转录-聚合酶链反应证实了胃饥饿素和GHS-R在大鼠肾上腺皮质中的表达,并且通过放射免疫分析(RIA)检测到肾上腺中免疫反应性胃饥饿素的浓度很高。放射自显影显示在肾上腺球状带(ZG)和束状带外层(ZF)中有大量的[¹²⁵I]胃饥饿素结合位点。胃饥饿素(浓度从10⁻¹⁰到10⁻⁸M)对分散的ZG细胞以及束状带/网状带(ZF/R)细胞的基础类固醇激素(孕烯醇酮、孕酮、11-脱氧皮质酮、皮质酮、18-羟皮质酮和醛固酮)分泌没有影响(通过定量高压液相色谱法评估),对培养的ZG细胞和ZF/R细胞的基础及激动剂刺激的醛固酮和皮质酮生成也没有影响(通过RIA测量)。胃饥饿素(10⁻⁸和10⁻⁶M)提高了培养的ZG细胞的基础增殖率,但不影响激动剂刺激的增殖率(能够掺入5-溴-2'-脱氧尿苷的细胞百分比),且不影响凋亡清除率(能够将生物素化核苷掺入凋亡DNA片段的细胞百分比)。酪氨酸激酶(TK)抑制剂 tyrphostin-23 和 p42/p44 丝裂原活化蛋白激酶(MAPK)抑制剂 PD-98059 消除了 10⁻⁸M 胃饥饿素的促增殖作用,而蛋白激酶A和C抑制剂H-89和钙泊三醇无效。胃饥饿素(10⁻⁸M)刺激了分散的ZG细胞的TK和MAPK活性,并且分别用tyrphostin-23和PD-98059预孵育可消除该作用。tyrphostin-23消除了胃饥饿素诱导的MAPK活性激活。综上所述,目前的研究结果表明:(i)胃饥饿素和GHS-R在大鼠肾上腺皮质中均有表达,胃饥饿素结合位点在ZG中非常丰富;(ii)胃饥饿素不影响大鼠肾上腺皮质细胞的分泌活性,但显著提高培养的ZG细胞的增殖率,且不影响凋亡清除率;(iii)胃饥饿素对ZG的促增殖作用涉及p42/p44 MAPK级联的TK依赖性激活。